Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-12-02 Sale |
2024-12-02 9:42 pm |
AYRO Inc. | AYRO | Silverman Joshua Executive Chairman |
6,166 | $0 | $0 | 286,691 (Direct) |
View |
2023-08-01 Sale |
2023-08-03 8:02 pm |
AYRO Inc. | AYRO | Silverman Joshua Director |
12,740 | $0.8152 | $10,386 | 395,493 (Direct) |
View |
2023-05-03 Sale |
2023-05-05 7:51 pm |
AYRO Inc. | AYRO | Silverman Joshua Director |
11,927 | $0.4874 | $5,813 | 408,233 (Direct) |
View |
2023-01-30 Sale |
2023-02-03 6:29 pm |
AYRO Inc. | AYRO | Silverman Joshua Director |
7,171 | $0.7123 | $5,108 | 420,160 (Direct) |
View |
2022-12-16 Sale |
2022-12-20 8:01 pm |
Synaptogenix Inc. | SNPX | Silverman Joshua Director |
19,012 | $1.1719 | $22,280 | 38,238 (Direct) |
View |
2022-05-11 Sale |
2022-11-03 9:04 pm |
AYRO Inc. | AYRO | Silverman Joshua Director |
20,026 | $0.73832 | $14,786 | 229,998 (Direct) |
View |
2021-11-24 Purchase |
2021-11-29 12:46 pm |
MyMD Pharmaceuticals Inc. | MYMD | Silverman Joshua Director |
15,000 | $6.8905 | $103,358 | 88,775 (Direct) |
View |
2021-06-14 Purchase |
2021-06-16 1:00 pm |
Synaptogenix Inc. | SNPX | Silverman Joshua Director |
10,000 | $8.3 | $83,000 | 15,000 (Direct) |
View |
2021-06-04 Sale |
2021-06-08 4:00 pm |
AYRO Inc. | AYRO | Silverman Joshua Director |
39,008 | $5.1704 | $201,687 | 136,467 (Indirect Direct) |
View |
2020-12-01 Sale |
2020-12-03 9:40 pm |
Neurotrope Inc. | NTRP | Silverman Joshua Director |
100,000 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-19 Option Award |
2025-02-21 5:33 pm |
N/A N/A |
Petros Pharmaceuticals Inc. | PTPI | Silverman Joshua Director |
1,000,000 | $0 | 1,011,237 (Direct) |
View |
2024-12-02 Option Award |
2024-12-02 9:42 pm |
N/A N/A |
AYRO Inc. | AYRO | Silverman Joshua Executive Chairman |
146,052 | $0 | 286,691 (Direct) |
View |
2024-12-02 Exercise |
2024-12-02 9:42 pm |
N/A N/A |
AYRO Inc. | AYRO | Silverman Joshua Executive Chairman |
97,368 | $0 | 286,691 (Direct) |
View |
2024-07-12 Option Award |
2024-07-15 4:39 pm |
N/A 2034-07-12 |
FEMASYS INC | FEMY | Silverman Joshua Director |
17,600 | $0 | 17,600 (Direct) |
View |
2024-04-08 Option Award |
2024-04-10 4:07 pm |
N/A 2034-04-08 |
Synaptogenix Inc. | SNPX | Silverman Joshua Director |
800 | $0 | 800 (Direct) |
View |
2023-12-21 Option Award |
2023-12-26 5:06 pm |
N/A 2033-12-21 |
Petros Pharmaceuticals Inc. | PTPI | Silverman Joshua Director |
40,000 | $0 | 40,000 (Direct) |
View |
2023-11-20 Option Award |
2023-11-22 5:01 pm |
N/A 2033-11-20 |
PharmaCyte Biotech Inc. | PMCB | Silverman Joshua Interim CEO, Interim President |
170,000 | $0 | 170,000 (Direct) |
View |
2023-11-21 Option Award |
2023-11-22 4:39 pm |
N/A 2033-11-21 |
FEMASYS INC | FEMY | Silverman Joshua Director |
17,000 | $0 | 17,000 (Direct) |
View |
2023-06-07 Option Award |
2023-06-09 6:00 pm |
N/A 2028-06-07 |
MyMD Pharmaceuticals Inc. | MYMD | Silverman Joshua Director |
200,000 | $0 | 200,000 (Direct) |
View |
2023-04-26 Exercise |
2023-04-28 6:00 pm |
N/A N/A |
Petros Pharmaceuticals Inc. | PTPI | Silverman Joshua Director |
6,722 | $0 | 11,237 (Direct) |
View |
2023-04-10 Option Award |
2023-04-12 6:01 pm |
N/A 2033-04-10 |
Petros Pharmaceuticals Inc. | PTPI | Silverman Joshua Director |
39,000 | $0 | 39,000 (Direct) |
View |
2023-03-29 Option Award |
2023-03-31 4:15 pm |
N/A 2033-03-29 |
Synaptogenix Inc. | SNPX | Silverman Joshua Director |
20,000 | $0 | 20,000 (Direct) |
View |
2023-02-01 Option Award |
2023-02-03 6:29 pm |
N/A N/A |
AYRO Inc. | AYRO | Silverman Joshua Director |
197,333 | $0 | 420,160 (Direct) |
View |
2023-01-20 Exercise |
2023-01-25 4:17 pm |
N/A N/A |
Petros Pharmaceuticals Inc. | PTPI | Silverman Joshua Director |
2,515 | $0 | 4,515 (Direct) |
View |
2021-07-13 Option Award(A) |
2022-12-01 7:52 pm |
N/A N/A |
Synaptogenix Inc. | SNPX | Silverman Joshua Director |
42,250 | $0 | 57,250 (Direct) |
View |
2022-11-15 Option Award(A) |
2022-12-01 7:50 pm |
N/A 2032-11-15 |
Synaptogenix Inc. | SNPX | Silverman Joshua Director |
75,000 | $0 | 75,000 (Direct) |
View |
2022-11-15 Option Award |
2022-11-17 4:03 pm |
N/A 2032-11-15 |
Synaptogenix Inc. | SNPX | Silverman Joshua Director |
144,000 | $0 | 144,000 (Direct) |
View |
Ownership |
2022-08-23 5:50 pm |
N/A N/A |
PharmaCyte Biotech Inc. | PMCB | Silverman Joshua Director |
0 | $0 | 50,000 (Indirect) |
View |
2022-04-05 Other(A) |
2022-06-23 6:01 pm |
N/A N/A |
Synaptogenix Inc. | SNPX | Silverman Joshua Director |
0 | $0 | 0 (Direct) |
View |
2022-04-07 Option Award |
2022-04-11 5:01 pm |
N/A N/A |
Petros Pharmaceuticals Inc. | PTPI | Silverman Joshua Director |
67,227 | $0 | 67,227 (Direct) |
View |
2022-04-05 Option Award |
2022-04-06 5:01 pm |
N/A 2032-04-05 |
Synaptogenix Inc. | SNPX | Silverman Joshua Director |
1,500 | $0 | 1,500 (Direct) |
View |
2022-02-01 Option Award |
2022-02-03 5:08 pm |
N/A N/A |
AYRO Inc. | AYRO | Silverman Joshua Director |
114,729 | $0 | 250,024 (Direct) |
View |
2021-12-22 Option Award |
2022-01-07 4:45 pm |
N/A N/A |
Petros Pharmaceuticals Inc. | PTPI | Silverman Joshua Director |
25,156 | $0 | 25,156 (Direct) |
View |
2021-10-14 Option Award |
2021-10-15 5:20 pm |
N/A N/A |
MyMD Pharmaceuticals Inc. | MYMD | Silverman Joshua Director |
600,000 | $0 | 600,000 (Direct) |
View |
2021-07-13 Option Award |
2021-07-15 6:04 pm |
N/A N/A |
Synaptogenix Inc. | SNPX | Silverman Joshua Director |
90,000 | $0 | 105,000 (Direct) |
View |
Ownership |
2021-06-14 8:16 pm |
N/A N/A |
Synaptogenix Inc. | SNPX | Silverman Joshua Director |
0 | $0 | 37,750 (Direct) |
View |
2021-04-16 Tax Withholding |
2021-04-20 9:35 pm |
N/A N/A |
MyMD Pharmaceuticals Inc. | MYMD | Silverman Joshua Director |
38,325 | $4.94 | 71,175 (Direct) |
View |
2021-04-16 Exercise |
2021-04-20 9:35 pm |
N/A N/A |
MyMD Pharmaceuticals Inc. | MYMD | Silverman Joshua Director |
109,500 | $0 | 71,175 (Direct) |
View |
2021-04-08 Option Award |
2021-04-09 4:15 pm |
N/A 2031-04-08 |
Petros Pharmaceuticals Inc. | PTPI | Silverman Joshua Director |
50,000 | $0 | 50,000 (Direct) |
View |
2021-02-24 Option Award |
2021-02-26 5:30 pm |
N/A N/A |
AYRO Inc. | AYRO | Silverman Joshua Director |
42,000 | $0 | 175,475 (Direct) |
View |
2020-09-29 Option Award(A) |
2020-12-28 1:28 pm |
N/A N/A |
AYRO Inc. | AYRO | Silverman Joshua Director |
122,547 | $0 | 132,303 (Direct) |
View |
2020-12-01 Option Award |
2020-12-02 9:10 pm |
N/A 2026-08-04 |
Petros Pharmaceuticals Inc. | PTPI | Silverman Joshua Director |
118,130 | $0 | 138,130 (Direct) |
View |